4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-030446
President & CEO sold 20,361 shares at $0.72 ($14,660)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2023-05-16 | Sale | −20,361 | $0.72 | $14,660 | 939,797 | D |
| Open-market sales · 20,361 sh · avg $0.72 · $14,660 | |||||||
Loading xslF345X04/doc4.xml…